Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
申请人:O'Neil Steven Victor
公开号:US20100273772A1
公开(公告)日:2010-10-28
Disclosed are compounds of Formula I:
pharmaceutical compositions containing compounds of Formula I, and the use of compounds of Formula I to treat diseases and disorders including schizophrenia, paranoia, depression, manic-depressive illness and anxiety wherein W
1
-W
5
, X
1
-X
4
, Y, Z
1
-Z
5
, m, n, p, and R
1
-R
6
in Formula I are defined in the specification.
A new strategy for catalytic functionalization of C-H bonds by means of electrochemical oxidation is described. Combination of palladium-catalyzed aromatic C-H bond cleavage and halogenation with electrochemically generated halonium ions enables highly efficient, selective halogenations of aromatic compounds in a green-sustainable manner. The required reagents for this reaction are an arene and an